Position in HLN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$301,752,035
-$15,752,402 QoQ
Shares Held
32,342,126
+2.0% QoQ
Ownership
0.735%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#3
of 639 holders
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clearbridge Investments, LLC holds $445,909,713 across 4 Drug Manufacturers - Specialty & Generic names. HLN ranks #1 (67.7% of the industry book) .
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $301,752,035 | 32,342,126 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $317,504,437 | 31,718,725 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $317,689,320 | 31,423,276 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $299,130,950 | 33,347,932 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $326,094,719 | 31,445,971 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $335,401,839 | 32,594,931 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $312,942,938 | 32,803,243 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $395,378,916 | 37,370,408 | Shares | Sole | 2024-11-12 | |
| 2024-03-31 | $326,414,843 | 38,446,978 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $218,769,053 | 26,581,902 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $216,325,951 | 25,969,502 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $212,934,786 | 25,409,879 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $207,695,828 | 25,515,458 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $205,639,048 | 25,704,881 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $119,457,670 | 19,615,381 | Shares | Sole | 2022-11-14 | |
| No filing history on record for this holder in this stock. | ||||||